Key result
Captopril increases active plasma renin ~2.7-fold at 2 hours in hypertensive patients.
Why the study?
The study examined changes in plasma active and inactive renin following oral administration of SQ 14225 (Captopril) in hypertensive patients.
Answers are grounded in this paper and cite their sources.
Acute captopril alters renin profiles in hypertension; leaves open therapeutic monitoring value.
The changes of active and inactive renin in plasma after the oral administration of 25 mg or 50 mg of SQ 14225 (Captopril) were studied in 29 hypertensive patients. Inactive renin was calculated as plasma renin activity (PRA) after cold storage minus PRA before cold storage. The patients were divided into 2 groups, responders and non-responders, according to the response of active renin to Captopril. In 9 responders, the active renin increased markedly while the inactive renin decreased. On the other hand, in 20 non-responders, both renin activities increased only slightly. These results suggest that inactive renin may be converted in vivo to active renin by Captopril.
No takes yet. Share an insight, caveat, or question.
Goto et al. (1980) studied Hypertension (n=29). Captopril (SQ 14225) vs. Baseline (pre-treatment control after 1 hr recumbent position) was evaluated on Active plasma renin activity at 2 hours post-administration (ng/ml) (p=<0.001). Captopril increased active plasma renin from 15.9 to 43.4 ng/ml at 2 hours while decreasing inactive renin at 1 hour in hypertensive patients.
Synapse has enriched 10 related papers. Consider them for comparative context: